CLGN News and Press, CollPlant Holdings Ltd. From 03/26/25

2025-03-26 19:59:08 ET More on CollPlant Biotechnologies CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on CollPlant Biotechnologies Historical earnings data for CollPlant Biotechnologies Financial i...

2025-03-26 19:58:48 ET CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Conference Call March 26, 2025, 10:00 AM ET Company Participants Dory Kurowski - LifeSci Advisors Yehiel Tal - CEO Eran Rotem - Deputy CEO and CFO Conference Call Participants ...

2025-03-26 08:14:09 ET More on CollPlant Biotechnologies Seeking Alpha’s Quant Rating on CollPlant Biotechnologies Historical earnings data for CollPlant Biotechnologies Financial information for CollPlant Biotechnologies Read the full article on See...

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE PR Newswire CollPlant announces six-month study data from its regenerative breast implant program, which could provide a revolutionary alternative to women for aesthetic or medical purpose...

Nu Ride Inc. - Class A (NRDE) is expected to report for quarter end 2024-12-31 Dalrada Financial Corp. (DFCO) is expected to report for quarter end 2024-12-31 HilleVax Inc. (HLVX) is expected to report $-0.38 for Q4 2024 Chewy Inc. Class A (CHWY) is expected to report $0.03 for Q4 202...

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION PR Newswire Conference call to be held on Wednesday, March 26, 2025 at 10:00 a.m. U.S. EST REHOVOT, Israel , March 19...

CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia PR Newswire REHOVOT, Israel , Feb. 24, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), or "CollPlant", a regenerative and aesthetics medicine company developing innovativ...

CollPlant Biotechnologies Provides a Corporate Update PR Newswire -  Additional patent granted for photocurable dermal filler -  Update on AbbVie dermal filler program and achievement of contingent payment -  Plan for cost reductions in place to extend cash ru...